Sotera Health will announce Q4 and full-year 2024 financial results on February 27, 2025, followed by a conference call.
Quiver AI Summary
Sotera Health Company has announced that it will release its financial results for the fourth quarter and full year ending December 31, 2024, before the market opens on February 27, 2025. Following the release, a conference call will be held at 9:00 a.m. Eastern Time to discuss the company’s performance, with dial-in options provided for participants from both the U.S. and other locations. The call will also be available via a live webcast on the company's website, with a replay accessible later the same day. Sotera Health, operating under brands like Sterigenics®, Nordion®, and Nelson Labs®, is a leading provider of sterilization solutions and lab testing for the healthcare industry, committed to “Safeguarding Global Health.”
Potential Positives
- The planned release of fourth-quarter and full-year financial results demonstrates transparency and accountability to investors.
- The conference call provides an opportunity for management to communicate directly with shareholders, potentially boosting investor confidence.
- The availability of a live webcast and a replay of the call increases accessibility for investors, enhancing engagement and information dissemination.
Potential Negatives
- The announcement does not provide specific financial expectations or guidance, which may indicate uncertainty or concern about future performance.
- There is no mention of any strategies or actions being taken to address potential challenges, which could raise questions among investors about the company's direction.
- The reliance on a future conference call for detailed financial results may suggest that the company is not currently in a stable position, prompting market speculation.
FAQ
When will Sotera Health announce its financial results for 2024?
Sotera Health will announce its financial results on February 27, 2025, before the market opens.
What time is the conference call for Sotera Health’s financial results?
The conference call will take place at 9:00 a.m. Eastern Time on February 27, 2025.
How can I participate in the Sotera Health conference call?
To join the call, dial 1-844-481-2916 from the U.S. or 1-412-317-0709 from other locations.
Is there a way to access the webcast of the conference call?
Yes, the live webcast can be accessed via the Investor Relations section of Sotera Health’s website.
Where can I find updates on Sotera Health's developments?
Updates can be found in the Investor Relations section of Sotera Health’s website, particularly under Ethylene Oxide or Presentation & Events.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SHC Insider Trading Activity
$SHC insiders have traded $SHC stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $SHC stock by insiders over the last 6 months:
- PINCUS & CO. WARBURG has made 0 purchases and 2 sales selling 30,000,000 shares for an estimated $450,900,000.
- INVESTMENT XI LLC GTCR sold 10,000,000 shares for an estimated $150,300,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SHC Hedge Fund Activity
We have seen 119 institutional investors add shares of $SHC stock to their portfolio, and 106 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SCULPTOR CAPITAL LP added 5,000,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $68,400,000
- JANUS HENDERSON GROUP PLC removed 4,886,228 shares (-38.6%) from their portfolio in Q4 2024, for an estimated $66,843,599
- MAVERICK CAPITAL LTD removed 3,497,367 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $47,843,980
- TWO SEAS CAPITAL LP added 2,496,136 shares (+624.0%) to their portfolio in Q4 2024, for an estimated $34,147,140
- CITADEL ADVISORS LLC removed 2,201,031 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $30,110,104
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,823,250 shares (-19.4%) from their portfolio in Q4 2024, for an estimated $24,942,060
- D. E. SHAW & CO., INC. added 1,534,666 shares (+140.8%) to their portfolio in Q4 2024, for an estimated $20,994,230
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2024 before the market opens on Thursday, February 27, 2025. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.
To participate in the live call, please dial 1-844-481-2916 if dialing-in from the United States, or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call can be accessed at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health , along with the accompanying materials. A replay of the webcast will be available later in the day on February 27th.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health . For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health .
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics ® , Nordion ® and Nelson Labs ® . Sotera Health is committed to its mission, Safeguarding Global Health ® .
INVESTOR RELATIONS CONTACTS:
Jason Peterson
Vice President, Investor Relations & Treasurer
[email protected]
MEDIA CONTACT:
Kristin Gibbs
Chief Marketing Officer
[email protected]
Source: Sotera Health Company
